Immunochemistry - Humoral Immunity - PowerPoint PPT Presentation

About This Presentation
Title:

Immunochemistry - Humoral Immunity

Description:

Molecules responsible for recognition of antigens and their mechanisms of action – PowerPoint PPT presentation

Number of Views:794

less

Transcript and Presenter's Notes

Title: Immunochemistry - Humoral Immunity


1
Immunochemistry Humoral Immunity
R. C. Gupta Professor and Head Dept. of
Biochemistry National Institute of Medical
Sciences Jaipur, India
2
E M B - R C G
3
E M B - R C G
4
E M B - R C G
5
E M B - R C G
6
Innate immunity
E M B - R C G
7
E M B - R C G
8
E M B - R C G
9
E M B - R C G
10
E M B - R C G
11
E M B - R C G
EMB-RCG
12
Acquired immunity
E M B - R C G
13

Acquired immunity comprises
E M B - R C G
EMB-RCG
14
Antigens
E M B - R C G
15
E M B - R C G
16
Haptens
E M B - R C G
17
E M B - R C G
18
Role of lymphocytes
E M B - R C G
19
E M B - R C G
20
E M B - R C G
21
Humoral immunity
E M B - R C G
22
(No Transcript)
23
(No Transcript)
24
Immunoglobulin light chains
Light chains are smaller than heavy chains
E M B - R C G
25
E M B - R C G
26
Immunoglobulin heavy chains
E M B - R C G
27
E M B - R C G
28
E M B - R C G
29
(No Transcript)
30
E M B - R C G
31
(No Transcript)
32
E M B - R C G
33
E M B - R C G
34
(No Transcript)
35
E M B - R C G
36
Action of papain
E M B - R C G
37
E M B - R C G
38
(No Transcript)
39
Antigen-antibody interaction
E M B - R C G
40
E M B - R C G
41
Effector mechanisms
E M B - R C G
42
Neutralization
E M B - R C G
43
Neutralization
44
Opsonisation
E M B - R C G
45
Opsonisation
46
Complement activation
E M B - R C G
47
Complement activation
Phagocyte
Antibody
48
Classification of immunoglobulins
E M B - R C G
49
Immuno- globulin class Heavy chains Light chains
IgA a k or l
IgG g k or l
IgD d k or l
IgE e k or l
IgM m k or l
E M B - R C G
50
Subclasses
E M B - R C G
51
IgG
E M B - R C G
52
EMB-RCG
53
IgA
E M B - R C G
54
(No Transcript)
55
Secretory IgA
E M B - R C G
56
(No Transcript)
57
E M B - R C G
58
IgM
E M B - R C G
59
(No Transcript)
60
IgE
E M B - R C G
61
EMB-RCG
62
IgD
Function of IgD is not known
EMB-RCG
63
Important features of Ig classes
Class of Ig
Plasma conc (mg/dl)
Half- life (days)
Active against
Bacteria and viruses
IgG
700-1,500
23
Strongly antiviral, weakly antibacterial
60-500
5-6
IgA
Strongly antibacterial, weakly antiviral
IgM
40-200
5-6
Anti-parasitic, mediates allergic reactions
IgE
0.01-0.1
2-3
Function not known
IgD
0.3-40
2-3
64
E M B - R C G
EMB-RCG
65
Idiotypes
E M B - R C G
66
Idiotype
67
Isotypes
E M B - R C G
68
E M B - R C G
69
Isotype
70
Allotypes
E M B - R C G
71
Allotype
72
Antibody diversity
E M B - R C G
73
E M B - R C G
74
Human beings can synthesize millions of unique
antibodies
E M B - R C G
So, we need millions of genes to encode the
huge repertoire of antibodies
However, the number of antibody genes in human
genome is less than 200
75
(No Transcript)
76
Gene re-arrangement
E M B - R C G
77
Light chain gene re-arrangement
E M B - R C G
78
E M B - R C G
79
E M B - R C G
80
E M B - R C G
81
E M B - R C G
82
E M B - R C G
83
E M B - R C G
84
Light chain gene re-arrangement
85
E M B - R C G
86
E M B - R C G
87
Heavy chain gene re-arrangement
E M B - R C G
88
E M B - R C G
89
E M B - R C G
90
E M B - R C G
91
E M B - R C G
92
E M B - R C G
93
Heavy chain gene-rearrangement
94
E M B - R C G
95
E M B - R C G
96
Combinatorial diversity
E M B - R C G
97
E M B - R C G
98
Junctional diversity
E M B - R C G
99
E M B - R C G
100
Somatic hypermutation
E M B - R C G
101
Re-arranged heavy chain gene
E M B - R C G
102
(No Transcript)
103
C Segments of heavy chain gene
104
E M B - R C G
105
Class switching
E M B - R C G
106
E M B - R C G
107
E M B - R C G
108
Class switching from IgM to IgA2
109
Primary response
E M B - R C G
110
(No Transcript)
111
E M B - R C G
112
(No Transcript)
113
E M B - R C G
114
(No Transcript)
115
E M B - R C G
116
Secondary response
E M B - R C G
117
(No Transcript)
118
Differentiation of B cells into plasma
cells
E M B - R C G
119
(No Transcript)
120
E M B - R C G
121
E M B - R C G
122
E M B - R C G
123
E M B - R C G
124
E M B - R C G
125
(No Transcript)
126
E M B - R C G
127
E M B - R C G
128
Immunization
E M B - R C G
129
E M B - R C G
130
E M B - R C G
131
E M B - R C G
132
Features of an effective vaccine
The vaccine itself should not cause disease or
death
Safe
Must protect against illness from exposure to
live pathogen
Protective
Protection should be long-lasting
Sustained effect
EMB-RCG
133
Passive immunity
E M B - R C G
134
E M B - R C G
135
Production of monoclonal antibodies
E M B - R C G
136
E M B - R C G
137
E M B - R C G
138
E M B - R C G
139
Procedure
E M B - R C G
140
E M B - R C G
141
E M B - R C G
142
Production of monoclonal antibodies
143
E M B - R C G
144
In HAT medium
E M B - R C G
145
(No Transcript)
146
Complement system
E M B - R C G
147
E M B - R C G
148
E M B - R C G
149

E M B - R C G
150
E M B - R C G
X ? Xa Xb
151
E M B - R C G
152
E M B - R C G
153
Classic complement cascade
E M B - R C G
154
E M B - R C G
155
E M B - R C G
156
E M B - R C G
157
Recognition phase
E M B - R C G
158
Complement system Recognition phase
159
E M B - R C G
160
(No Transcript)
161
E M B - R C G
162
(No Transcript)
163
Membrane attack phase
C5a
C5
C8
C6 C7
164
E M B - R C G
165
(No Transcript)
166
Lectin pathway
E M B - R C G
167
E M B - R C G
168
(No Transcript)
169
(No Transcript)
170
Alternate complement pathway
E M B - R C G
171
E M B - R C G
172
E M B - R C G
173
E M B - R C G
174
(No Transcript)
175
E M B - R C G
176
(No Transcript)
177
Allergy
Allergy is described as a side effect of immunity
E M B - R C G
It is an altered immune response to an otherwise
innocuous antigen
Antigens evoking an allergic response are called
allergens
EMB-RCG
178
(No Transcript)
179
E M B - R C G
EMB-RCG
180
E M B - R C G
EMB-RCG
181
E M B - R C G
EMB-RCG
182
EMB-RCG
183
EMB-RCG
184
E M B - R C G
EMB-RCG
185
E M B - R C G
EMB-RCG
Write a Comment
User Comments (0)
About PowerShow.com